Archive for January, 2010

Public health and bovine tuberculosis

Tuesday, January 19th, 2010

Cow Historically, tuberculosis caused by Mycobacterium bovis (bovine tuberculosis, bTB) was a major public health issue in the UK. bTB in humans was widespread in the UK before the introduction of pasteurisation of milk in the 1960s: in the 1930s, 40% of dairy cows were infected and 0.5% had tuberculous mastitis. During this period, approximately 2500 people died annually from bTB. Therefore, measures were introduced to eliminate bTB from the UK. As a result, by the 1970s, bTB was eliminated from most of Britain, with persistent infection limited to the southwest. Subsequently, bTB has re-emerged: in 2007, there were 4172 new herd breakdowns in England and Wales. The resurgence of bTB has resulted in public expenditure now approaching £100 million annually. More and more extreme measures are being proposed to stop the spread of the disease such as widespread badger culling programmes, despite scientific studies casting doubt on the efficacy of such practices.

This article argues that, apart from milk pasteurisation, these measures no longer make economic sense and hence are now resulting in gross misallocation of public resources. We are therefore of the opinion that there is no public health rationale for the multimillion bTB control programme in the UK provided that milk continues to be pasteurised. The logical conclusion arising from this is that without a public health perspective, bTB is essentially an endemic animal disease and hence any control programme should be economically effective in terms of improvements in animal health and welfare and industry profitability or viability.

Public health and bovine tuberculosis: what’s all the fuss about? Trends in Microbiology, Nov 25 2009
Bovine tuberculosis (bTB) in UK cattle is increasing rapidly. Consequently, the UK Government is spending escalating sums of money in attempts at disease control. We propose that bTB control in cattle is irrelevant as a public health policy. In the UK, cattle-to-human transmission is negligible. Aerosol transmission, the only probable route of human acquisition, occurs at inconsequential levels when milk is pasteurised, even when bTB is highly endemic in cattle. Furthermore, there is little evidence for a positive cost benefit in terms of animal health of bTB control. Such evidence is required; otherwise, there is little justification for the large sums of public money spent on bTB control in the UK.

Related:

A century of Toxoplasma gondii research

Monday, January 18th, 2010

A century of Toxoplasma gondii research Cats are the source of the parasite Toxoplasma gondii which infects many people but only causes disease in an unlucky few. In this article in Microbiology Today (pdf) Fiona Henriquez and Craig Roberts describe the history of research into this important organism and the direction of future investigations which hopefully will lead to the discovery of a treatment for the infection:

A century of Toxoplasma gondii research is a protozoan parasite that can be transmitted directly from cats to humans through faecal contamination of food, or indirectly from cats to livestock and then to humans through undercooked meat. Around 30% of humans in the United Kingdom are infected, and as such, harbour dormant cysts in their brain, but few have overt symptoms of disease. Neurological disease can occur in these people if they become immunosuppressed. The possibility that apparently healthy people with infection are more likely to develop psychiatric disease, including schizophrenia and depression, is under investigation. Infection during pregnancy can cause abortion or foetal infection. Congenital disease can result in systemic, neurological and progressive eye disease. No vaccine exists for prevention of infection or disease and current drug treatments are not entirely effective.

Read more

Related:


Phage Wars 2

Friday, January 15th, 2010

Phage Wars 2

Phage Wars 2 is a fast paced, strategy game built around genetically modifying viruses. Your goal is to create the most powerful virus ever by defeating all the other genetically engineered viruses in.

Have fun!

Microbial diseases and coral reefs

Thursday, January 14th, 2010

Elkhorn coral Tropical coral reefs harbour a reservoir of enormous biodiversity that is increasingly threatened by direct human activities and indirect global climate shifts. Emerging coral diseases are one serious threat implicated in extensive reef deterioration through disruption of the integrity of the coral holobiont – a complex symbiosis between the coral animal, endobiotic alga and an array of microorganisms. In this article, the authors review the current understanding of the role of microorganisms in coral health and disease, and highlight the pressing interdisciplinary research priorities required to elucidate the mechanisms of disease. They advocate an approach that applies knowledge gained from experiences in human and veterinary medicine, integrated into multidisciplinary studies that investigate the interactions between host, agent and environment of a given coral disease. These approaches include robust and precise disease diagnosis, standardised ecological methods and application of rapidly developing DNA, RNA and protein technologies, alongside established histological, microbial ecology and ecological expertise. Such approaches will allow a better understanding of the causes of coral mortality and coral reef declines and help assess potential management options to mitigate their effects in the longer term.

The role of the environment in coral disease epizootics has been a major focus of investigations because coral reefs are the ecosystem facing the most rapidly advancing threat from climate change. Corals are sessile organisms and have the advantage that individual animals can be tracked in the wild to monitor disease progression. Significant challenges in framing the scale, complexity and natural variability of emerging coral diseases throughout the world’s oceans include a lack of historical baseline data sets and a wide diversity of ecological factors that influence disease patterns on both regional and global scales. Progress has been made to clarify the effects and drivers of coral disease on local and regional scales, and the field continues to refine the methods of coral disease assessment. However, developing a meaningful understanding of the interactions between the environment, the agent and the host is still required.

Microbial disease and the coral holobiont. Trends in Microbiology 17 (12) 554-562, 2009. doi:10.1016/j.tim.2009.09.004

Related:

Climate change influences infectious disease in the Arctic and the tropics

Wednesday, January 13th, 2010

Climate Climate change is incontestably a phenomenon of global causes and impacts. However, as the contribution of different regions and countries to climate change differs, so do the impacts. This paper examines the current and potential impact of climate change on infectious diseases in regions that could not be more different: the Arctic and the tropics. Despite obvious differences in environmental and socio-economic contexts, there are commonalities between these areas, both in the mechanisms through which climate change influences disease transmission and in the adaptation responses health systems can and should mount. The authors consider five main common characteristics and requirements, respectively, regarding climate-sensitive infectious diseases:

  1. Exposure to new patterns of climate-sensitive infectious diseases.
  2. Disease surveillance and early warning systems.
  3. Health system preparedness.
  4. Enhanced global efforts towards developing drugs and vaccines.
  5. Common challenges for research.

Climate change influences infectious diseases both in the Arctic and the tropics: joining the dots. Glob Health Action 2: 11 November 2009. doi: 10.3402/gha.v2i0.2106

Related:

Clustering of MRSA strains across Europe

Tuesday, January 12th, 2010

map Staphylococcus aureus is the main cause of purulent infection in humans. S. aureus has the potential for local as well as disseminated infection and can cause lesions in all tissues and anatomical sites. Infections can be either acquired in the community or in association with health care. The position of S. aureus as one of the most important human pathogens is largely due to its virulence potential and ubiquitous occurrence as a coloniser in humans, domestic animals, and livestock. Between 25% and 35% of healthy human individuals carry S. aureus on the skin or mucous membranes. Any injury that compromises epithelial integrity, trauma, medical or surgical interventions, as well as viral infections, can lead to tissue invasion. It is assumed that severity and outcome depend largely on the virulence of the introduced strain and the immune repertoire of the host. Occasionally, S. aureus acquires enhanced virulence and antimicrobial resistance through horizontal DNA transfer and maintains these mobile genetic elements in a predominantly clonal genomic background. Thus, clones of S. aureus are relatively stable and mainly diversify by the accumulation of single nucleotide substitutions in the absence of frequent interstrain recombination. It is therefore possible to discern different clones and clonal lineages by molecular typing. This method allows several important observations to be made regarding the evolution, epidemiology, and spread of clones with particular public health importance, such as hospital-, community- , and livestock-associated methicillin-resistant S. aureus (MRSA).

A new study finds that methicillin-resistant S. aureus (MRSA), responsible for several difficult-to-treat infections including blood poisoning and pneumonia and a particular problem in hospitals, occurs in distinct geographical clusters across Europe, indicating that MRSA is being diffused by patients moving between hospitals rather than spreading freely in the community. The study used an interactive Web tool to map different strains of the Staphylococcus aureus bacterium across the continent. MRSA infections have become more prevalent in hospitals over the past ten years, and information about its geographical distribution could help us to understand how it spreads and how to control it.

Since 2006 a large group of collaborators in 450 European hospitals located in 26 different countries collected both MRSA and methicillin-sensitive S. aureus (MSSA) isolates from infected patients. National laboratories identified specific strains of S. aureus by molecular typing and entered this information into a Web-based mapping application which is publicly available. The results show that strains of MRSA tend to cluster within regional borders and, in several instances, were associated with individual hospitals. This suggests that MRSA is mainly spread by patients who are repeatedly admitted to different hospitals. Control efforts aimed at interrupting the spread within and between health care institutions may not only be feasible but ultimately successful.

Geographic Distribution of Staphylococcus aureus Causing Invasive Infections in Europe: A Molecular-Epidemiological Analysis. PLoS Med 7(1): e1000215 doi:10.1371/journal.pmed.1000215:
Staphylococcus aureus is one of the most important human pathogens and methicillin-resistant variants (MRSAs) are a major cause of hospital and community-acquired infection. We aimed to map the geographic distribution of the dominant clones that cause invasive infections in Europe. In each country, staphylococcal reference laboratories secured the participation of a sufficient number of hospital laboratories to achieve national geo-demographic representation. Participating laboratories collected successive methicillin-susceptible (MSSA) and MRSA isolates from patients with invasive S. aureus infection using an agreed protocol. All isolates were sent to the respective national reference laboratories and characterised by quality-controlled sequence typing of the variable region of the staphylococcal spa gene (spa typing), and data were uploaded to a central database. Relevant genetic and phenotypic information was assembled for interactive interrogation by a purpose-built Web-based mapping application. Between September 2006 and February 2007, 357 laboratories serving 450 hospitals in 26 countries collected 2,890 MSSA and MRSA isolates from patients with invasive S. aureus infection. A wide geographical distribution of spa types was found with some prevalent in all European countries. MSSA were more diverse than MRSA. Genetic diversity of MRSA differed considerably between countries with dominant MRSA spa types forming distinctive geographical clusters. We provide evidence that a network approach consisting of decentralised typing and visualisation of aggregated data using an interactive mapping tool can provide important information on the dynamics of MRSA populations such as early signalling of emerging strains, cross border spread, and importation by travel. In contrast to MSSA, MRSA spa types have a predominantly regional distribution in Europe. This finding is indicative of the selection and spread of a limited number of clones within health care networks, suggesting that control efforts aimed at interrupting the spread within and between health care institutions may not only be feasible but ultimately successful and should therefore be strongly encouraged.

Related:

An update on Legionella

Monday, January 11th, 2010

Legionnaires disease
Legionnaires’ disease has been in the news recently. This recent article gives a good update of the current state of knowledge around this illness:

An update on Legionella. Curr Opin Infect Dis. Jan 4 2010
Legionella pneumophila is increasingly recognized as a significant cause of sporadic and epidemic community-acquired and nosocomial-acquired pneumonia. This review focuses on the latest literature concerning the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of Legionnaires’ disease. A significant increase in the incidence of Legionnaires’ disease in the United States has been documented over the last years. L. pneumophila has recently been found to be a leading cause of community-acquired pneumonia in hospitalized and ambulatory patients in Germany. Recent studies provide insight into the understanding of the pathogenesis of Legionnaires’ disease and the relevance of the formation of biofilms. Clinical manifestations of Legionnaires’ disease are not specific and current diagnostic scores are of limited use. Several recent studies offer useful information concerning Legionnaires’ disease in immunosuppressed patients. A systematic review of English literature performed to assess test characteristics of Legionella urinary antigen has found that the pooled sensitivity of the test was 0.74 and specificity was 0.991. Improved clinical response has been observed for patients with Legionnaires’ disease treated with highly active antimicrobial agents against Legionella. Legionnaires’ disease is a significant health problem in many countries. Clinical manifestations are unreliable in diagnosing Legionnaires’ disease. Therefore, diagnostic laboratory tests for Legionella, including the urinary antigen test, should be applied to all patients with pneumonia. Levofloxacin (or other fluoroquinolone) or azithromycin are the current drugs of choice for treatment of Legionnaires’ disease. Effective preventive strategies are needed.

Related:

High Tech Fungi

Friday, January 8th, 2010

mycorrhiza Ectomycorrhizal (ECM) fungi form a mutualistic symbiosis with tree roots and play key roles in forest ecosystems. In return for receiving nutrients and water from the soil via the roots, they receive carbohydrates as photosynthate from their host plants. As is the case for other soil fungal species, the composition of the ECM community is affected by both biotic and abiotic factors; these include climate changes, seasons, soil micro-site heterogeneity, soil and litter quality, host tree species and forest management. To describe in more detail the impact of environmental factors on community composition, long-term, year-round monitoring and a detailed spatial description of the community has to be carried out. However, analyses are very often hindered by a limited sample number and by the ephemeral or cryptic lifestyle of the fungi.

Over the last fifteen years, PCR-based molecular methods and DNA sequencing of nuclear and mitochondrial ribosomal DNA have been used routinely to identify mycorrhizal fungi. However, these methods are timeconsuming and are limited in the number of samples that can be treated in a realistic time frame. With automated molecular genotyping techniques, appropriate DNA databases and a better knowledge of internal transcribed spacer (ITS) variability within fungal species, identification of fungal taxa in environmental samples can now be expanded from the aforementioned methods to high-throughput molecular diagnostic tools, such as phylochips. So far, DNA arrays have been mainly used for genome-wide transcription profiling, but also for the identification of bacterial species from complex environmental samples or for the identification of a few genera of pathogenic fungi and Oomycetes.

Phylochips may comprise up to several thousand probes that target phylogenetic marker genes, such as 16S rRNA in bacteria or the ITS region in fungi. Phylochips have several advantages over traditional approaches, including higher specificity, cost efficiency, rapid identification and detection of target organisms, and the high numbers of samples throughput; therefore, they are increasingly used for the detection of bacterial and pathogenic fungi. In the ECM fungal ecology field, the first application of ribosomal DNA arrays was to develop a specific phylochip (on nylon membranes) to detect Suilloid fungi. Recently, this approach has also been used for truffle identification. No previous study has reported the construction and application of an ECM fungal phylochip to detect a large number of ECM fungal species that belong to various genera from environmental samples. This paper reports the first application of a custom ribosomal ITS phylochip to describe the community composition of ECM fungi on roots. The phylochip carried specific oligonucleotides for 95 fungal species that belong to 25 ECM fungal genera. The specificity of the oligonucleotides was evaluated using ITS amplicons of known reference species. The method was then used to describe ECM fungal communities that were obtained from 30-year-old spruce and beech plantations. The phylochip approach should be an attractive method for routine, accurate and reproducible monitoring of fungal species on specific sites, in which a high sample throughput is required.

Development and validation of an oligonucleotide microarray to characterise ectomycorrhizal fungal communities. BMC Microbiology 2009, 9: 241 doi:10.1186/1471-2180-9-241
In forest ecosystems, communities of ectomycorrhizal fungi (ECM) are influenced by biotic and abiotic factors. To understand their underlying dynamics, ECM communities have been surveyed with ribosomal DNA-based sequencing methods. However, most identification methods are both time-consuming and limited by the number of samples that can be treated in a realistic time frame. As a result of ongoing implementation, the array technique has gained throughput capacity in terms of the number of samples and the capacity for parallel identification of several species. Thus far, although phylochips (microarrays that are used to detect species) have been mostly developed to trace bacterial communities or groups of specific fungi, no phylochip has been developed to carry oligonucleotides for several ectomycorrhizal species that belong to different genera. We have constructed a custom ribosomal DNA phylochip to identify ECM fungi. Specific oligonucleotide probes were targeted to the nuclear internal transcribed spacer (ITS) regions from 95 fungal species belonging to 21 ECM fungal genera. The phylochip was first validated using PCR amplicons of reference species. Ninety-nine percent of the tested oligonucleotides generated positive hybridisation signals with their corresponding amplicons. Cross-hybridisation was mainly restricted at the genus level, particularly for Cortinarius and Lactarius species. The phylochip was subsequently tested with environmental samples that were composed of ECM fungal DNA from spruce and beech plantation fungal communities. The results were in concordance with the ITS sequencing of morphotypes and the ITS clone library sequencing results that were obtained using the same PCR products. To overcome cross-hybridisation problems, specific filter and evaluation strategies that used spot signal intensity were applied. Evaluation of the phylochip by hybridising environmental samples confirmed the possible application of this technology for detecting and monitoring ectomycorrhizal fungi at specific sites in a routine and reproducible manner.

Related:

The Bornavirus in all of us

Thursday, January 7th, 2010

Bornavirus Even before I wrote my online notes about Bornaviruses over 10 years ago, this group of viruses was always a bit of a mystery. Considerable controversy still surrounds the role of these viruses in human pathogenesis, so it is of great interest that a report has just been published in Nature describing how Bornavirus-like sequences have been repeatedly incorporated into the genome during mammalian evolution. BDV infection might create a source of mutation in infected individuals, which allows a testable hypothesis for the alleged, but still controversial, causative association of BDV infection with certain psychiatric disorders, such as schizophrenia and mood disorders.

Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 463, 84, (2010). doi:10.1038/nature08695
Retroviruses are the only group of viruses known to have left a fossil record, in the form of endogenous proviruses, and approximately 8% of the human genome is made up of these elements. Although many other viruses, including non-retroviral RNA viruses, are known to generate DNA forms of their own genomes during replication, none has been found as DNA in the germline of animals. Bornaviruses, a genus of non-segmented, negative-sense RNA virus, are unique among RNA viruses in that they establish persistent infection in the cell nucleus. Here we show that elements homologous to the nucleoprotein (N) gene of bornavirus exist in the genomes of several mammalian species, including humans, non-human primates, rodents and elephants. These sequences have been designated endogenous Borna-like N (EBLN) elements. Some of the primate EBLNs contain an intact open reading frame (ORF) and are expressed as mRNA. Phylogenetic analyses showed that EBLNs seem to have been generated by different insertional events in each specific animal family. Furthermore, the EBLN of a ground squirrel was formed by a recent integration event, whereas those in primates must have been formed more than 40 million years ago. We also show that the N mRNA of a current mammalian bornavirus, Borna disease virus (BDV), can form EBLN-like elements in the genomes of persistently infected cultured cells. Our results provide the first evidence for endogenization of non-retroviral virus-derived elements in mammalian genomes and give novel insights not only into generation of endogenous elements, but also into a role of bornavirus as a source of genetic novelty in its host.

Related: